Cytokeratin Fragment 19 eCLIA is an immunoassay reagent for in vitro quantitative determination of Cytokeratin Fragment 19 (CYFRA21-1) in human serum and plasma by automated immunassay analyzer to aid diagnosis of non-small cell lung cancer.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.